Verastem, Inc. (VSTM)

6d ago, source: Yahoo Finance

This strategic move has expanded Viking Global's holding to a total of 2,531,829 shares in Verastem Inc, reflecting the firm's confidence in the company's future prospects. On February 6 ...

Verastem: Financial Resilience and Promising Drug Pipeline Despite Short-Term Losses

1mon ago, source: Business Insider

Begin your TipRanks Premium journey today. Verastem (VSTM) Company Description: Verastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developing and ...

Verastem’s Strategic Advancements and Financial Stability Underscore Buy Rating

28d ago, source: Business Insider

Begin your TipRanks Premium journey today. Verastem (VSTM) Company Description: Verastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developing and ...

Verastem gets grant for dual RAF/MEK inhibitor for cancer treatment in solid form

5d ago, source: Pharmaceutical Technology

Discover the latest patent from Verastem Inc for a dual RAF/MEK inhibitor, covering solid forms, pharmaceutical compositions, and cancer treatment methods. Explore the unique characteristics of Form 1 ...

Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer

5d ago, source:

Dr. Hayslip to lead development programs for avutometinib, including Verastem Oncology’s international confirmatory Phase 3 RAMP 301 clinical trial, and advance pipeline assets ...

Verastem, Inc. (VSTM) stock price, news, quote & history – Yahoo Finance

20d ago, source: Yahoo Finance

BOSTON, April 04, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock options to ...

Verastem, Inc. (VSTM) Stock Historical Prices & Data - Yahoo Finance

5d ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

VIRX Viracta Therapeutics, Inc.

8h ago, source: Seeking Alpha

Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. Its lead product ...

Verastem Inc

28d ago, source: U.S. News & World Report

Analysts say investors should buy these undervalued stocks.

Verastem, Inc. (VSTM)

20d ago, source: Yahoo Finance

BOSTON, April 04, 2024--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock options to ...